Clinical Trials Sponsored by Laboratorios Hipra, S.A.

Total 300 results

Laboratorios Hipra, S.A.

Completed

Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)

Covid19 | SARS CoV 2 Infection

Spain
Hipra Scientific, S.L.U
Laboratorios Hipra, S.A.

Completed

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Hipra Scientific, S.L.U
National Institute of Hygiene and Epidemiology, Vietnam; Laboratorios Hipra...

Completed

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Vietnam
Laboratorios Viñas, S.A.
Hospital Vall d'Hebron; Laboratorio Echevarne

Completed

Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) (MELATOZINC)

Fatigue Syndrome, Chronic | Myalgic Encephalomyelitis

Spain
Laboratorios Viñas, S.A.
Hospital Vall d'Hebron; Laboratorio Echevarne

Recruiting

Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MelatoZincME)

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis

Spain
Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage

Skin Care

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil (FORASMA)

Moderate Asthma

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil (ALERZIN)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar Extraction (OXIFEN)

Pain

Brazil
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Therapeutic Equivalency

India
Laboratorios Andromaco S.A.

Completed

Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product

Bioequivalence

India
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

Bioequivalence

India
Eurofarma Laboratorios S.A.

Completed

UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit. (HEPIRC)

Hemodialysis Complication
Laboratorios Andromaco S.A.

Completed

Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product

Bioequivalence

India
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clotiazepam 5 mg With Regards to Reference Product

Bioequivalence

Chile
Eurofarma Laboratorios S.A.

Completed

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL) (GLACIAL)

Osteoarthritis of Knee

Brazil
Eurofarma Laboratorios S.A.

Completed

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Mild to Moderate Persistent Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab (NICAP)

Carcinoma | Head and Neck Cancer

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease (PANDA)

Gastroesophageal Reflux Disease

Brazil
Eurofarma Laboratorios S.A.

Completed

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

Asthma

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma (UNIK)

Asthma

Brazil
Eurofarma Laboratorios S.A.

Unknown

Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension (CARD)

Arterial Hypertension

Brazil
Igefarma Laboratorios S.A.

Completed

Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate

Acne Vulgaris

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) (TRIPLAR)

Chronic Obstructive Pulmonary Disease

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of the Protection of a Liquid Bandage

Skin Care

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment (RESFRIN)

Cold | Flu Symptom

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine

Migraine

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer

Breast Cancer

India
Eurofarma Laboratorios S.A.

Withdrawn

Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil (BENCOX)

Third Molar Extraction

Brazil
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee (Artico)

Osteoarthritis of the Knee

Brazil
Eurofarma Laboratorios S.A.

Terminated

Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

Congestive Heart Failure

Brazil
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Laboratorios Andromaco S.A.

Completed

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis (RINEX32)

Rhinitis, Allergic, Perennial

Brazil
Laboratorios Andromaco S.A.

Completed

Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve

Infertility, Female | Healthy Women

Chile
Laboratorios Andromaco S.A.

Completed

Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea

Dysmenorrhea

Chile
Eurofarma Laboratorios S.A.

Unknown

The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women

Memory Disorders | Postmenopausal Symptoms

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy

Breast Cancer
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago

Acute Lumbago

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia (Eszo)

INSOMNIA

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) (CECI)

Cystitis
Eurofarma Laboratorios S.A.

Completed

Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis (NOEX)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Neutropenia in Breast Cancer

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia (LAILAII)

Lactose Intolerance

Brazil
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain (Dextra)

Lumbar Sciatic Pain

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients With Asthma (CAINAS SF)

Asthma

Brazil
Eurofarma Laboratorios S.A.

Completed

A Comparative Study Between Foraseq And Formoterol/Budesonide Inhalation Capsules in Patients With Asthma (CAINAS)

ASTHMA

Brazil

3

Subscribe